Literature DB >> 12974337

Neurological signs and results of magnetic resonance imaging in 40 cavalier King Charles spaniels with Chiari type 1-like malformations.

D Lu1, C R Lamb, D U Pfeiffer, M P Targett.   

Abstract

In human beings a Chiari type 1 malformation is a developmental condition characterised by cerebellar herniation and syringohydromyelia. Abnormalities compatible with such a malformation were identified by magnetic resonance imaging in 39 cavalier King Charles spaniels with neurological signs and in one neurologically normal cavalier King Charles spaniel that was examined postmortem. The dogs with these abnormalities had a wide variety of neurological signs, but there was no apparent correlation between the neurological signs and the severity of cerebellar herniation, syringohydromyelia or hydrocephalus.

Entities:  

Mesh:

Year:  2003        PMID: 12974337     DOI: 10.1136/vr.153.9.260

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  18 in total

1.  Syringomyelia in the Cavalier King Charles spaniel (CKCS) dog.

Authors:  Katheryn C Wolfe; Roberto Poma
Journal:  Can Vet J       Date:  2010-01       Impact factor: 1.008

2.  Increase in cerebellar volume in Cavalier King Charles Spaniels with Chiari-like malformation and its role in the development of syringomyelia.

Authors:  Thomas A Shaw; Imelda M McGonnell; Colin J Driver; Clare Rusbridge; Holger A Volk
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

3.  Comparison of the Relationship between Cerebral White Matter and Grey Matter in Normal Dogs and Dogs with Lateral Ventricular Enlargement.

Authors:  Martin J Schmidt; Steffi Laubner; Malgorzata Kolecka; Klaus Failing; Andreas Moritz; Martin Kramer; Nele Ondreka
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

4.  Magnetic resonance imaging signs of high intraventricular pressure--comparison of findings in dogs with clinically relevant internal hydrocephalus and asymptomatic dogs with ventriculomegaly.

Authors:  Steffi Laubner; Nele Ondreka; Klaus Failing; Martin Kramer; Martin J Schmidt
Journal:  BMC Vet Res       Date:  2015-08-01       Impact factor: 2.741

5.  Prevalence of Chiari-like malformations in clinically unaffected dogs.

Authors:  T R Harcourt-Brown; J Campbell; C Warren-Smith; N D Jeffery; N P Granger
Journal:  J Vet Intern Med       Date:  2014-10-15       Impact factor: 3.333

6.  Low-field MRI and multislice CT for the detection of cerebellar (foramen magnum) herniation in Cavalier King Charles Spaniels.

Authors:  K Kromhout; H van Bree; B J G Broeckx; S Bhatti; L Van Ham; I Polis; I Gielen
Journal:  J Vet Intern Med       Date:  2014-11-19       Impact factor: 3.333

7.  Changes over time in craniocerebral morphology and syringomyelia in cavalier King Charles spaniels with Chiari-like malformation.

Authors:  Colin J Driver; Luisa De Risio; Sarah Hamilton; Clare Rusbridge; Ruth Dennis; Imelda M McGonnell; Holger A Volk
Journal:  BMC Vet Res       Date:  2012-11-08       Impact factor: 2.741

8.  Volume reduction of the jugular foramina in Cavalier King Charles Spaniels with syringomyelia.

Authors:  Martin Jürgen Schmidt; Nele Ondreka; Maren Sauerbrey; Holger Andreas Volk; Christoph Rummel; Martin Kramer
Journal:  BMC Vet Res       Date:  2012-09-06       Impact factor: 2.741

9.  Comparison of the endocranial- and brain volumes in brachycephalic dogs, mesaticephalic dogs and Cavalier King Charles spaniels in relation to their body weight.

Authors:  Martin J Schmidt; Kerstin H Amort; Klaus Failing; Melanie Klingler; Martin Kramer; Nele Ondreka
Journal:  Acta Vet Scand       Date:  2014-05-13       Impact factor: 1.695

10.  Prevalence and heritability of symptomatic syringomyelia in Cavalier King Charles Spaniels and long-term outcome in symptomatic and asymptomatic littermates.

Authors:  M S Thøfner; C L Stougaard; U Westrup; A A Madry; C S Knudsen; H Berg; C S E Jensen; R M L Handby; H Gredal; M Fredholm; M Berendt
Journal:  J Vet Intern Med       Date:  2014-10-10       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.